Weight-loss drugmaker Eli Lilly has unveiled an ambitious plan to build a $3.5 billion manufacturing complex in the heart of Pennsylvania’s Lehigh Valley—a historic investment that could reshape the region’s housing market.
The Indiana-based company, which makes the weight management treatment Zepbound and the diabetes medication Mounjaro, will build a 925,000-square-foot complex consisting of multiple buildings at the Fogelsville Corporate Center in Upper Macungie Township, just outside Allentown, PA.
Construction is scheduled to begin later this year and be completed by 2031, creating 850 jobs at the facility, according to a press release from Lehigh Valley Economic Development Corp…